Skip to main content
. Author manuscript; available in PMC: 2014 Dec 1.
Published in final edited form as: Mol Cancer Ther. 2013 Oct 15;12(12):2827–2836. doi: 10.1158/1535-7163.MCT-13-0383

Figure 5.

Figure 5

H&E tissue sections of MAD109 tumors. Representative sections from mice receiving (A) no pretreatment, (B) VP-16 (30 mg/kg) 2 days prior, (C) VP-16 (30 mg/kg) 3 days prior, and (D) VP-16 (30 mg/kg) 5 days prior to receiving 64Cu-Sar-chTNT-3. Mice were sacrificed 1 day later and tumors were stained with H&E. The largest areas of necrosis from each section are shown on the right at 40× magnification, with areas of necrosis outlined in black.